Clinical and histopathological prognostic factors in chondrosarcomas

Sarcoma

Volumn 1, Issue 1, 1997, Pages 47-54

  Daugaard, Søren ^a   Myhre Jensen, Olaf ^b   Schiødt, Torben ^a   Jurik, Anne G ^b   Keller, Johnny ^b   Mouridsen, Henning T ^a   Lund, Bjarne ^a  

^a University of Copenhagen   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chondrosarcoma; Clinical parameters; Grade; Histopathological parameters; Inter observer variation; Prognosis

Indexed keywords

EID: 2942521738     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577149778470     Document Type: Article

References (29)

1. van Oosteroom AT, Dirix LY. Chondrosarcoma and other rare bone sarcomas. Curr Opin Oncol 1990; 2:495-9.
2. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 1977; 40:818-31.
3. Gitelis S, Bertoni F, Picci P, et al. Chondrosarcoma of Bone. J Bone Joint Surg 1981; 63A:1248-57.
4. Huvos AG. Bone tumors: diagnosis, treatment, and prognosis, 2nd edn. Philadelphia: WB Saunders, 1991.
5. Schajowicz F. Tumors and tumorlike lesions of bone. Pathology, radiology and treatment, 2nd edn. Berlin: Springer, 1994.
6. Fechner RE, Mills SE. Tumors of the bones and joints. Atlas of tumor pathology, 3rd series. Washington DC: Armed Forces Institute of Pathology, 1993.
7. Salisbury JR, Woods CG, Byers PD. Diseases of bones and joints. London: Chapman & Hall Medical, 1994.
8. Enneking WF. Clinical musculoskeletal pathology, 3rd edn. Gainsville, FL: University of Florida Press, 1990.
9. Svanholm H, Starklint H, Gundersen HJG, et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 1989; 97:689-98.
10. Gjørup T. The Kappa coefficient and the prevalence of a diagnosis. Meth Inform Med 1988; 27:184-6.
11. Burt M, Fulton M, Wessner-Dunlap S, et al. Primary bony and cartilaginous sarcomas of chest wall: results of therapy. Ann Thorac Surg 1992; 54:226-32.
12. Ozaki T, Lindner N, Hillmann A, et al. Influence of intralesional surgery on treatment outcome of chondrosarcoma. Cancer 1996; 77:1292-7.
13. Ruark DS, Schlehaider UW, Shah JP. Chondrosarcomas of the head and neck. World J Surg 1992; 16:1010-16.
14. Pritchard DJ, Lunke RJ, Taylor WF, et al. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 1980; 45:149-57.
15. Kreicbergs A, Boquist L, Borssén B, et al. Prognostic factors in chondrosarcoma. A comparative study of cellular DNA content and clinicopathologic features. Cancer 1982; 50:577-83.
16. Kreicbergs A, Slezak E, Söderberg G. The prognostic significance of different histomorphologic features in chondrosarcoma. Virchows Arch A Pathol Anat Histol 1981; 390:1-10.
17. Zeppa P, Zabatta A, Marino G, et al. A morphometric approach to the grading of chondroid tumours on fine-needle smears. Pathol Res Pract 1989; 185:760-3.
18. Ishida T, Kikuchi F, Machinami R. Histological grading and morphometric analysis of cartilaginous tumours. Virchows Arch A Pathol Anat 1991; 418:149-55.
19. Kreicbergs A, Zetterberg A. Cytophotometric DNA measurements of chondrosarcoma. Analyt Quant Cytol 1980; 2:84-92.
20. Dijkhuizen T, van den Berg E, Molenaar WM, et al. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas. Cancer Genet Cytogenet 1994; 76:100-5.
21. Bridge JA, Bhatia PS, Anderson JR, et al. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet 1993; 69:79-90.
22. Hansen M, Sindrup SH, Christensen PB, et al. Interobserver variation in the evaluation of neurological signs: observer dependent factors. Acta Neurol Scand 1994; 90:145-9.
23. Sørensen JB, Hirsch FR, Gazdar A, et al. Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma. Cancer 1993; 71:2971-6.
24. Morris JA. Information and observer disagreement in histopathology. Histopathology 1994; 25:123-8.
25. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58:306-9.
26. Ohno T, Tanaka T, Takeuchi S, et al. Silver-stained nucleolar organizer proteins in chondrosarcoma. Virchows Archiv B Cell Pathol 1991; 60:207-11.
27. Coughlan B, Feliz A, Ishida T, et al. p53 expression and DNA ploidy of cartilage lesions. Hum Pathol 1995; 26:620-4.
28. Hasegawa T, Seki K, Yang P, et al. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol 1995; 26:838-45.
29. Nawa G, Ueda T, Mori S, et al. Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Int J Cancer 1996; 69:86-91.